| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $344.2M | +3.7% |
| Cost of Revenue | $71.0M | +18.0% |
| R&D Expense | $51.9M | -0.4% |
| SG&A Expense | $229.3M | +14.6% |
| Operating Income | -$42.8M | -593.8% |
| Income Tax | -$5.4M | -261.4% |
| Net Income | -$24.2M | -232.4% |
| EPS (Basic) | -$0.83 | -225.8% |
| EPS (Diluted) | -$0.83 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $116.7M | -2.5% |
| Short-term Investments | $182.8M | +5.4% |
| Accounts Receivable | $43.4M | -15.3% |
| Inventory | $10.3M | +26.0% |
| Current Assets | $361.1M | +0.3% |
| Total Assets | $578.6M | +8.9% |
| Current Liabilities | $68.7M | +39.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $64.3M | -0.8% |
| Capital Expenditures | $36.0M | +27.2% |
| Investing Cash Flow | -$60.4M | -20.4% |
| Financing Cash Flow | -$7.0M | -213.4% |
| Free Cash Flow | $28.3M | -22.5% |
| -233.9% |
| Long-term Debt |
| $10.1M |
| +0.3% |
| Total Liabilities | $107.7M | +42.8% |
| Stockholders' Equity | $470.9M | +3.3% |